Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies - PharmaTimes Partnership will analyse m6A RNA modifications in patient samples to support development of STC‑15

#biomarkerdevelopment #biomarkers #StormTherapeutics #AlidaBio #RNAtargetingcancertherapies #RNAmodifyingenzyme #cancerbiology #RNAmaturation #RNAtransport #RNAtranslation #RNAmodificationanalysis #NGStechnologies #precisiononcology #nextgenerationcancertherapeutics
zurl.co/lWe8q

STORM Therapeutics and Alida Bio Unite to Enhance Development of Cancer Treatments through RNA Modifications STORM Therapeutics and Alida Bio have announced a collaboration aimed at advancing cancer therapies by focusing on RNA modifications, leveraging advanced sequencing technologies for groundbreaking treatment insights.

STORM Therapeutics and Alida Bio Unite to Enhance Development of Cancer Treatments through RNA Modifications #Cambridge #United_Kingdom #STORM_Therapeutics #AlidaBio #RNA_modifications

AlidaBio Launches EpiPlex™ Duo-Mod™ Service for Comprehensive RNA Modification Analysis AlidaBio has unveiled the EpiPlex™ Duo-Mod™ Service, an innovative solution for simultaneous mapping of m6A and inosine RNA modifications coupled with RNA expression profiling, enhancing research capabilities.

AlidaBio Launches EpiPlex™ Duo-Mod™ Service for Comprehensive RNA Modification Analysis #USA #San_Diego #AlidaBio #EpiPlex #RNA_modifications